Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.